Safety and Efficacy of Using the New Tissue Containment System During Laparoscopic Myomectomy Morcellation

Exclusion Criteria

• •• Women with Known or suspected malignancy
• •* patients with severe pelvic adhesion found during the operation
• •* The body mass index of the patient ≥ 28kg/m2
• •* Diameter of a single uterine fibroid\>10cm
• •* patients during pregnancy and lactation
• •* Known blood diseases, bleeding coagulation disease, any part of the active bleeding or bleeding tendency of the constitution of the patient
• •* Patients with known severe liver and kidney dysfunction;Liver function (ALT, AST) ≥ 2 times of normal upper limit, or renal function (Cr) ≥ normal upper limit
• •* Patients who are known to have participated in any other clinical trial within 3 months
• •* Patients who cannot sign informed consent
• •* Patients with acute stage infection of the reproductive system or other sites